Role of NOD2 gene in Crohn's disease
Hugot, J.-P.
Gastroenterologie Clinique et Biologique 26(1): 13-15
2002
ISSN/ISBN: 0399-8320 PMID: 11938034 Document Number: 544120
Document emailed within 1 workday
Related Documents
Goebell, H.; Wienbeck, M.; Schomerus, H.; Malchow, H. 1990: Evaluation of the Crohn's Disease Activity Index (CDAI) and the Dutch Index for severity and activity of Crohn's disease. An analysis of the data from the European Cooperative Crohn's Disease Study Medizinische Klinik 85(10): 573-576Auer, I.O.; Röder, A.; Mittelstaedt, A. 1985: Treatment of Crohn's disease using Colibiogen. Cellular reactions of the immune system in patients with Crohn's disease Fortschritte der Medizin 103(46): 1076-1080
Hut'an, M.; Hut'an, M.m. 2009: The role of surgery in Crohn's disease treatment Rozhledy V Chirurgii: Mesicnik Ceskoslovenske Chirurgicke Spolecnosti 88(4): 185-188
Xia, S.; Lin, X.; Guo, M.; Jiang, L.; Jin, J.; Lin, X.; Ding, R.; Li, S.; Jiang, Y. 2015: An analysis of vitamin D receptor gene polymorphisms and serum 25-hydroxyvitamin D levels in patients with Crohn's disease Zhonghua Nei Ke Za Zhi 54(7): 601-606
Manconi, G.; Sainaghi, M.; Alvisi, V.; Ricci, G.; Greco, S.; Bianchi Porro, G. 2003: Clinical role of bowel ultrasound in Crohn's disease Romanian Journal of Gastroenterology 12(2): 143-146
Bury, T.F.; van Vroonhoven, T.J.; Stuifbergen, W.N. 1988: The role of surgical intervention in the treatment of patients with Crohn's disease Nederlands Tijdschrift Voor Geneeskunde 132(53): 2414-2417
Baca-Estrada, M.E.; Croitoru, K. 1995: Alterations in the cytotoxic activity of Crohn's disease peripheral blood T cells expressing different T-cell receptor variable gene products Advances in Experimental Medicine and Biology 371b: 1293-1296
Purrmann, J.; Stelzner, M.; Brunner, H.; Borchard, F.; Ehms, H.; Welters, B.; Miller, B.; Strohmeyer, G. 1987: Role of Pseudomonas maltophilia and "Pseudomonas like bacteria group Va" in the etiology of Crohn disease Zeitschrift für Gastroenterologie 25(12): 749-755
Moravcova, J.; Regner, J.; Mouckova, D.; Fiser, K.; Zmekova, V.; Malacova, R.; Michalova, K.; Klamova, H. 2005: Disease status in patients with chronic myeloid leukemia is better characterized by BCR-ABL/BCR transcript ratio than by BCR-ABL transcript level, which may suggest a role of normal BCR gene in the disease pathogenesis Neoplasma 52(2): 119-125
Etienne, A.M.; Dupuis, G. 2011: Maladie de Crohn et qualité de vie: des pistes d'intervention : Etudes cliniques récentes en thérapie comportementale et cognitive chez l'enfant, l'adolescent et l'adulte - Crohn's disease and quality of life: methods of intervention Perspectives Psychiatriques (Paris) 50(3): 246-255
Aldenhoven, M.; Klomp, L.W.; van Hasselt, P.M.; de Koning, T.J.; Visser, G. 2007: From gene to disease; Menkes disease: copper deficiency due to an ATP7A-gene defect Nederlands Tijdschrift Voor Geneeskunde 151(41): 2266-2270
Elsner, J.; Kiehl, P.; Kapp, A.; Weiss, J. 1996: Erythema elevatum et diutinum bei Morbus Crohn : Klinischer Verlauf als Hinweis einer gemeinsamen Ätiologie ? - Erythema elevatum diutinum and Crohn's disease. Clinical course as evidence of a common etiology ? Hautarzt 47(9): 701-704
Kirsner, J.B. 1999: "Nonspecific" inflammatory bowel disease (ulcerative colitis and Crohn's disease) after 100 years--what next? Italian Journal of Gastroenterology and Hepatology 31(8): 651-658
Puleo, A.; Cappello, M.; Orlando, A.; Dardanoni, G.; Oliva, L.; Cottone, M. 1986: An evaluation of the laboratory parameters useful in the determination of disease activity in Crohn disease Recenti Progressi in Medicina 77(11): 511-514
Kruis, W.; Pfaff, G.; Lamerz, R.; Eisenburg, J. 1977: CEA blood level in patients with Crohn's disease with reference to localization, duration and severity of the disease Fortschritte der Medizin 95(47-48): 2795-2798
Akolkar, P.N.; Gulwani-Akolkar, B.; Heresbach, D.; Lin, X.Y.; Fisher, S.; Katz, S.; Silver, J. 1997: Differences in risk of Crohn's disease in offspring of mothers and fathers with inflammatory bowel disease American Journal of Gastroenterology 92(12): 2241-2244
Bamba, S.; Tsujikawa, T.; Ban, H.; Imaeda, H.; Inatomi, O.; Nishida, A.; Sasaki, M.; Andoh, A.; Fujiyama, Y. 2014: Predicting Mucosal Healing in Crohn's Disease Using Practical Clinical Indices with Regard to the Location of Active Disease Hepato-Gastroenterology 61(131): 689-696
Doe, W.F.; Booth, C.C.; Brown, D.L. 1973: Evidence for complement-binding immune complexes in adult coeliac disease, Crohn's disease, and ulcerative colitis Lancet 1(7800): 402-403
Harada, T.; Suzuki, N.; Mizushima, Y.; Sakane, T. 1994: Usage of a novel class of germ-line Ig variable region gene for cationic anti-DNA autoantibodies in human lupus nephritis and its role for the development of the disease Journal of Immunology 153(10): 4806-4815
García López, S. 2008: Inflammatory bowel disease. If a patient with Crohn's disease remains in remission for 4 years with azathioprine (or mercaptopurine), should the drug be withdrawn? Gastroenterologia y Hepatologia 31(10): 704-705